Impact of COVID-19 on ASOs, CBOs, and Service Providers

The course of the COVID-19 pandemic in the United States echoes that of HIV over the past four decades, with racial and ethnic groups and sexual and gender minorities bearing a disparate burden of both diseases. The pandemic has further exacerbated the psychosocial determinants that have created barriers to HIV prevention and health services for many people at risk and living with HIV. This session will review the results of the COVID-19 Rapid Risk and Resiliency Project (R3A), an exploratory sequential multiple methods study that sought to produce a deeper understanding of the lived experiences of HIV service providers (clinical and non-clinical) and customers of HIV prevention and care services in Washington, DC and Maryland.

The presentation will outline the facilitators, barriers, lessons learned and best practices. It will further engender a discussion about next steps in providing HIV prevention and care services during a pandemic, including support for rapid adoption of service delivery models; restoring access to services for customers of HIV prevention and care services; and introducing changes to strengthen systems capacity to prepare for future disruptions.


Circe Gray Le Compte, Senior Director of Health Services Research and Evaluation at HealthHIV

Erin Starzyk, Director of Health Services Research and Evaluation, HealthHIV

Gerran Thomas, Clinical Capacity Building Assistance Manager at HealthHIV

Visit for information on claiming and receiving CME/CE credits for this session.